市场调查报告书
商品编码
1438186
到 2030 年超音波诊断设备市场预测:按产品、显示器类型、便携性、连接性、应用、最终用户和地区进行的全球分析Ultrasound Devices Market Forecasts to 2030 - Global Analysis By Product (Therapeutic Ultrasound, Diagnostic Ultrasound and Other Products), Display Type, Portability, Connectivity, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2023 年全球超音波诊断设备市场规模为 85 亿美元,预计在预测期内复合年增长率为 8.3%,到 2030 年将达到 148 亿美元。
超音波诊断设备是一种使用高频声波产生体内结构即时影像的医疗工具。这种非侵入性设备通常用于诊断目的,并允许器官、组织和血流的可视化。透过发射声波并捕捉其反射,超音波技术有助于检查各种医疗状况,帮助医疗保健专业人员准确诊断和规划治疗。超音波诊断设备因其安全性、多功能性和软组织成像的有效性而广泛应用于产科、循环系统和其他医学专业。
根据美国心臟协会 (AHA) 的数据,2020 年,光是美国就有超过 1.027 亿成年人至少有一种心血管疾病。预计到 2035 年,这一数字将增至 1.312 亿。心臟病每年造成美国政府约 2,190 亿美元的损失。
慢性病增加
心血管疾病、癌症和肌肉骨骼疾病等疾病的日益普及增加了对超音波诊断设备等先进诊断工具的需求。这些设备在慢性病的早期检测、监测和治疗计划中发挥关键作用,推动了市场成长。超音波技术的不断进步为医疗保健专业人员提供了更准确、更有效率的诊断能力,进一步促进了市场的扩张。
影像品质和解释方面的挑战
操作员技能的差异会影响影像撷取的一致性并导致诊断差异。组织介面和身体习惯会产生伪影并妨碍准确解释。此外,技术限制可能会阻碍精确诊断所需的解析度。由于操作员依赖性、组织伪影以及肥胖患者的普及有限等因素,市场在影像品质和解释方面面临挑战。
医疗保健支出增加
由于慢性病的增加和人口老化,对超音波诊断设备的需求不断增加。这些设备提供非侵入性且经济高效的诊断解决方案,促进了全球的普及。此外,产科、心臟病学和肌肉骨骼成像领域的不断扩大的应用也促进了市场的成长。然而,与先进超音波技术的研究、开发和製造相关的成本不断上升,导致整个市场的医疗保健成本增加。
设备高成本
高设备成本仍然是市场的主要挑战。先进的技术、复杂的製造流程和不断的创新导致製造成本不断上升。严格的监管要求和品质标准进一步增加了製造成本。高成本是普及的障碍,限制了这种重要诊断工具的使用,特别是在资源匮乏的环境中。
COVID-19 的疫情对市场产生了重大影响。由于超音波诊断设备在诊断与病毒相关的呼吸道併发症方面发挥关键作用,对诊断超音波设备的需求增加,但市场面临供应链中断和择期手术延迟等挑战。这场大流行加速了携带式和照护现场超音波诊断设备的采用,超音波诊断设备快速有效的诊断。儘管最初遇到挫折,超音波诊断设备市场正在适应不断变化的医疗保健环境,创新和技术进步塑造了市场復苏和未来成长。
诊断超音波产业预计将在预测期内成为最大的产业
诊断超音波领域预计将在预测期内成为最大的领域。这种非侵入性成像技术使用高频声波来创建内部结构的即时影像。市场成长是由技术进步、慢性病盛行率增加以及对照护现场诊断的需求增加所推动的。不断的技术创新使得超音波诊断设备便携、更易于使用、用途更加广泛,从而在各个医疗领域中广泛采用。
预计蓝牙领域在预测期内复合年增长率最高
预计蓝牙产业在预测期内将出现最高的复合年增长率。这项创新可实现无缝连接,并促进超音波诊断设备与其他设备之间的高效资料传输。这项发展不仅改善了整体使用者体验,也有助于推动照护现场诊断的进步。由于对简化和互连医疗保健解决方案的需求不断增长,支持蓝牙的超音波诊断设备市场持续扩大。
预计北美在预测期内将占据最大的市场占有率。对可携式紧凑型超音波诊断设备以促进照护现场诊断的需求不断增长。此外,老化人口的增加也促进了市场的扩张。这是因为超音波广泛应用于各种医疗应用。该地区的主要参与者正专注于产品创新和策略联盟,进一步推动超音波设备领域的市场发展。
由于医疗保健基础设施的改善和对诊断影像服务的需求不断增长,预计亚太地区在预测期内将保持最高的复合年增长率。技术进步,加上社会老化,正在促进市场扩张。在医疗保健现代化和慢性病流行的持续努力的推动下,市场轨迹预计将保持上升。
According to Stratistics MRC, the Global Ultrasound Devices Market is accounted for $8.5 billion in 2023 and is expected to reach $14.8 billion by 2030 growing at a CAGR of 8.3% during the forecast period. Ultrasound devices are medical tools that utilize high-frequency sound waves to produce real-time images of internal structures within the body. These non-invasive devices are commonly employed for diagnostic purposes, enabling visualization of organs, tissues, and blood flow. By emitting sound waves and capturing their reflections, ultrasound technology facilitates the examination of various medical conditions, aiding healthcare professionals in accurate diagnoses and treatment planning. Ultrasound devices are widely used in obstetrics, cardiology, and other medical specialties due to their safety, versatility, and effectiveness in imaging soft tissues.
According to the American Heart Association (AHA), in the US alone, more than 102.7 million adults had at least one cardiovascular condition as of 2020. This number is projected to rise to 131.2 million by 2035. Heart disease costs the US government about USD 219 billion each year.
Rising prevalence of chronic diseases
The increasing incidence of conditions such as cardiovascular diseases, cancer, and musculoskeletal disorders has led to a growing need for advanced diagnostic tools like ultrasound devices. These devices play a crucial role in early detection, monitoring, and treatment planning for chronic illnesses, thereby driving market growth. The continuous technological advancements in ultrasound technology further contribute to the market's expansion, providing more accurate and efficient diagnostic capabilities for healthcare professionals.
Challenges in image quality and interpretation
Operator skill variations can impact the consistency of image acquisition, leading to diagnostic discrepancies. Tissue interfaces and body habitus can generate artifacts, hindering accurate interpretation. Additionally, technological limitations may hinder the resolution needed for precise diagnostics. The market faces challenges in image quality and interpretation, stemming from factors such as operator dependence, tissue artifacts, and limited penetration in obese patients.
Rising healthcare expenditure
The rising prevalence of chronic diseases, coupled with a growing aging population, is amplifying the need for ultrasound devices. These devices offer non-invasive and cost-effective diagnostic solutions, fueling their adoption globally. Additionally, expanding applications in obstetrics, cardiology, and musculoskeletal imaging contribute to market growth. However, the escalating costs associated with research, development, and manufacturing of advanced ultrasound technologies contribute to the overall increase in healthcare expenditure within the market.
High cost of equipment
The high cost of equipment remains a significant challenge in the market. The advanced technology, intricate manufacturing processes, and constant innovation contribute to elevated production expenses. Stringent regulatory requirements and quality standards further increase manufacturing costs. The high cost poses a barrier to widespread adoption, particularly in resource-constrained settings, limiting accessibility to this critical diagnostic tool.
The COVID-19 pandemic has significantly impacted the market. While the demand for ultrasound devices increased due to their crucial role in diagnosing respiratory complications associated with the virus, the market faced challenges such as disrupted supply chains and delayed elective procedures. The pandemic accelerated the adoption of portable and point-of-care ultrasound devices for quick and efficient diagnostics. Despite initial setbacks, the ultrasound devices market is adapting to the evolving healthcare landscape, with innovations and technological advancements shaping its recovery and future growth.
The diagnostic ultrasound segment is expected to be the largest during the forecast period
The diagnostic ultrasound segment is expected to be the largest during the forecast period. This non-invasive imaging technology utilizes high-frequency sound waves to create real-time images of internal body structures. The market's growth is propelled by technological advancements, increasing prevalence of chronic diseases, and the rising demand for point-of-care diagnostics. With continuous innovation, ultrasound devices are becoming more portable, user-friendly, and versatile, driving their widespread adoption across diverse medical specialties.
The bluetooth segment is expected to have the highest CAGR during the forecast period
The bluetooth segment is expected to have the highest CAGR during the forecast period. This innovation enables seamless connectivity, facilitating efficient data transfer between ultrasound machines and other devices. This development not only improves the overall user experience but also contributes to the advancement of point-of-care diagnostics. The Bluetooth in ultrasound devices market continues to expand, driven by the growing demand for streamlined and interconnected healthcare solutions.
North America is projected to hold the largest market share during the forecast period. The demand for portable and compact ultrasound devices is rising, facilitating point-of-care diagnostics. Additionally, a growing aging population contributes to the market expansion, as ultrasound is widely used in various medical applications. Key players in the region are focusing on product innovation and strategic collaborations, further fueling market development in the ultrasound devices sector.
Asia Pacific is projected to hold the highest CAGR over the forecast period owing to increased healthcare infrastructure development and rising demand for diagnostic imaging services. Advancements in technology, coupled with a growing aging population, contribute to the expanding market. The market's trajectory is expected to remain upward, propelled by ongoing healthcare modernization efforts and the prevalence of chronic diseases.
Key players in the market
Some of the key players in Ultrasound Devices market include GE HealthCare, Canon Inc., Analogic Corporation, Fujifilm Holdings Corporation , Samsung Medison Co., Ltd., Toshiba Medical Systems Corporation, Siemens Healthineers AG, Philips Healthcare, Hitachi, Ltd., Mindray Bio-Medical Electronics Co., Ltd., Alpinion Medical Systems Co., Ltd., Supersonic Imagine, Trivitron Healthcare,, Terason Corporation, Exact Imaging Inc. and Medical Technologies Co.
In February 2023, GE HealthCare has acquired Caption Health, thereby expanding the capabilities of ultrasound technology to assist new users through FDA-cleared, AI-powered image guidance. By leveraging Caption AI applications, ultrasound examinations can be streamlined, accelerating the process and empowering a wider range of healthcare professionals to perform fundamental echocardiogram exams.
In November 2022, Canon Inc. revealed its plans to form a new subsidiary called Canon Healthcare USA, Inc. With this strategic move, Canon intends to enhance its position within the influential American medical market and expedite the expansion of its medical business.
In October 2022, Fujifilm corporation, received regulatory approval for its latest generation endoscopic ultrasound endoscope (EG-740UT) and achieves compatibility of its ultrasound endoscope line-up with the flagship ARIETTA Ultrasound system of Fujifilm Healthcare.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.